Phase II study of m-AMSA in advances malignant melanoma

A phase II study of methanesulfonamide, N-(4-(9 acridinylamino)-3-methoxyphenyl)-(m-AMSA) was undertaken by the Eastern Cooperative Oncology Group. Thirty-five evaluable patients were studied, 18 of whom had had no prior therapy and eight of whom had been treated only one cytotoxic drug. Thirty-one...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of clinical oncology 1982-08, Vol.5 (4), p.433
Hauptverfasser:	Arseneau, J C, Wolter, J M, Probert, J C, Kuperminc, M
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aminoacridines - adverse effects Aminoacridines - therapeutic use Amsacrine Drug Evaluation Female Humans Leukopenia - chemically induced Male Melanoma - drug therapy Middle Aged Nausea - chemically induced Neoplasm Metastasis Skin Neoplasms - drug therapy Vomiting - chemically induced
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!